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an Coronary Computed
omographic Angiography
rigger Coronary
evascularization?
uestioning the Appropriateness of the Question*
aniel S. Berman, MD,† James K. Min, MD‡
os Angeles, California; and New York, New York
ultidetector computed tomography angiography
MDCTA) performed by scanners with 64-detector rows
as emerged as an accurate noninvasive method for detec-
ion and exclusion of severe coronary artery stenoses—
ypically graded at the 50% or 70% threshold—and is now
ommonly used in clinical practice for the assessment of
ndividuals with suspected or known coronary artery disease
CAD) (1–3). In this issue of JACC: Cardiovascular Inter-
entions, Sarno et al. (4) report the results of a small,
rospective single-center study of 81 individuals undergoing
DCTA, invasive coronary angiography (CA), and frac-
ional flow reserve (FFR) in order to evaluate the suitability
f a 50% stenosis by MDCTA to serve as an anatomic
tandard for determining appropriateness of coronary le-
ions for coronary intervention. Importantly, the definition
f “appropriateness” was based upon treatment consider-
tions after identification of functional significance; namely,
evascularization of a “significant stenosis,” functionally
efined by an FFR 0.75, was considered appropriate.
See page 550
In this study, concordance between MDCTA and CA
as good (kappa 0.74). However, diagnostic performance
f both MDCTA and CA to detect a functionally signifi-
ant stenosis was poor with per-patient sensitivity and
pecificity of 80% and 65%, and 67% and 75%, respectively.
Editorials published in JACC: Cardiovascular Interventions reflect the views of the
uthors and do not necessarily represent the views of JACC: Cardiovascular Interven-
ions or the American College of Cardiology.
From †Departments of Imaging (Division of Nuclear Medicine), Department of
edicine (Division of Cardiology), and CSMC Burns & Allen Research Institute,
edars-Sinai Medical Center; Department of Medicine, University of California at
os Angeles, School of Medicine, Los Angeles, California; and the ‡Department of
edicine and Radiology, Weill Medical College of Cornell University, The Newc
ork Presbyterian Hospital, New York, New York. Drs. Berman and Min have
eceived grant support from GE.ith a strict anatomic definition by MDCT at the 50%
tenosis threshold, rates of inappropriate revascularization
22%) and inappropriate deferral of revascularization (7%)
ased on MDCTA alone were non-negligible. While com-
ined evaluation of both anatomic severity of coronary
rtery stenosis by MDCTA and flow limitation as assessed
y FFR resulted in a much higher proportion of “appropri-
te” decision-making (91%), the authors concluded that
DCTA does not reliably predict functional significance of
oronary artery stenoses or need for revascularization. The
ndings of Sarno et al. (4) are very similar to those from a
tudy by Gaemperli et al. (5), who evaluated 79 patients
ndergoing MDCTA, CA, and FFR. Within this latter
tudy, the diagnostic accuracy of MDCTA to detect a
oronary lesion with an FFR 0.75 was only 49%.
The findings by Sarno et al. are in accord with the
ecently-published FAME (Fractional Flow Reserve ver-
us Angiography for Multivessel Evaluation) study of
,005 patients with multivessel CAD randomized to
FR-guided percutaneous coronary intervention (PCI)
ersus angiographically-guided PCI on the basis of CA
6). This study demonstrated a 28% relative risk reduc-
ion in adverse CAD event rates with the FFR-guided
CI— defined by death, myocardial infarction, or repeat
oronary revascularization—at a 1-year follow-up, although
o differences were noted for symptomatic anginal status.
he results of the FAME trial suggests that CA identifi-
ation of anatomic coronary artery stenosis is insufficient for
dentifying suitability for coronary revascularization and that
dentification of lesion-specific ischemia is necessary for deter-
ining future clinical benefit from coronary revascularization.
Traditionally, diagnostic performance studies of MDCTA
ave assessed stenosis severity, comparing it with quantita-
ive coronary angiography (QCA) as a reference standard.
he use of QCA as a comparator with MDCTA is a logical
ne, because intraluminal stenosis severity is assessed by
oth approaches. By this criterion, MDCTA has performed
ell (1–3).
The QCA threshold for “significant” coronary artery
tenosis detection in prior MDCTA diagnostic accuracy
tudies has been variable, with some using 50% stenosis and
ome using 70% stenosis as a cutoff of anatomic significance.
hese data arise from landmark studies using positron
mission tomography that demonstrate significant reduc-
ions in myocardial blood flow at the 50% stenosis thresh-
ld, which became much more dramatic at the 70%-stenosis
hreshold (7,8). In this regard, the 70%-stenosis threshold
as now become the generally accepted angiographic mea-
ure of anatomic significance, given the wide variability of
unctional reduction in myocardial blood flow within the
0% to 69% stenosis range. In this regard, the recent
ppropriateness Criteria for Coronary Revascularization (9)
tate that a 70% stenosis is the angiographic standard for
onsideration of revascularization. Furthermore, because
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559rior studies (10) indicate that MDCTA tends toward
verestimation of plaque stenosis severity—in particular, for
alcified plaque—it would seem that a 70% stenosis severity
riterion rather than the 50% criterion would have been
ore “appropriate” for use in the Sarno et al. study (4).
Given that the definitions of “appropriate” and “inappro-
riate” in the Sarno study are based upon treatment deci-
ions from functional rather than anatomic significance, it is
erhaps not surprising that MDCTA performed poorly.
ven when CA is the standard, the recently published
merican College of Cardiology Appropriateness Criteria
f Coronary Revascularization judge appropriateness not
nly by summary measures of coronary anatomy (including
he 70% definition of stenosis) but also by patient symp-
oms and, in certain cases, noninvasive testing results (9).
ow could MDCTA, with lower resolution than CA be
eld to a higher standard? In this regard, Sarno et al. seem
o have set up MDCTA to be a “strawman.” If functional
ignificance as measured by FFR is to be the criteria for
hich lesions are judged, then any anatomic measure of
tenosis that cannot assess coronary flow reserve will invari-
bly fail. Indeed, in this study, CA also fails to identify
ppropriate lesions for revascularization, and the probabi-
istic likelihood of MDCTA to identify functionally signif-
cant lesions is not different from CA.
Furthermore, underlying this study is a presupposition
hat the purpose of noninvasive cardiac imaging should be
o determine the appropriateness of coronary revasculariza-
ion. This is in direct contrast with the tenets that the fields
f noninvasive imaging have followed for the past 30 years.
t its core, the principal purposes of noninvasive cardiac
maging are two-fold, namely, to diagnose or exclude
oronary artery disease by defining its extent and severity,
nd to predict outcomes on the basis of image-specific
ndings (11).
For the first of these criteria, MDCTA has performed
xcellently, with sensitivity and specificity for CAD by CA
learly higher than those of any other noninvasive test.
eyond diagnostic performance, however, an accruing
rowing evidence base indicates that MDCTA permits risk
tratification as robust as that associated with other nonin-
asive tests, such as myocardial perfusion scintigraphy
MPS). Individuals with greater extent and severity of CAD
s identified by MDCTA are at greater risk for future
dverse CAD events. In contrast, those individuals identi-
ed as having no or minimal CAD by MDCTA have a long
warranty” period that seems to extend to at least 7 years (12).
This characteristic of MDCTA should not be over-
ooked. Indeed, the most “appropriate” patient cohort for
oninvasive cardiac imaging evaluation is the intermediate-
isk population, because patients with low and high pre-test
isk—in accordance with Bayes’ theorem—will not be
ufficiently reclassified by positive or negative testing, re-pectively. In this regard, in an intermediate-risk popula-
ion, the majority of individuals evaluated by noninvasive
esting will not have severe CAD, and a test that can safely
xclude CAD is useful for identification of individuals in
hom no further testing—including CA—is necessary.
Although it might be then tempting to extrapolate the
FR findings of this study and the FAME trial to nonin-
asive methods that are capable of assessing the functional
ignificance of CAD, to date there are limited data to
uggest that these tests—including electrocardiography,
PS, positron emission tomography, and stress echocardi-
graphy—in conjunction with coronary anatomy are able to
etermine “appropriateness” of coronary revascularization.
n the recent nuclear substudy of the COURAGE (Clinical
utcomes Utilizing Revascularization and Aggressive Drug
valuation) trial, there was suggestive evidence that patients
ith moderate-to-severe ischemia by MPS and angio-
raphic coronary artery stenoses of anatomic significance
ight benefit from PCI plus optimal medical therapy versus
ptimal medical therapy alone (13). However, this substudy
f 314 patients was insufficiently powered to fully address
his possibility. Further study of the use of noninvasive
tudies to guide decisions for CA and coronary revascular-
zation is needed.
Thus, the criteria for using noninvasive tests for deter-
ining appropriateness of coronary revascularization are a
ork-in-progress. Whether similar results to the FAME
tudy can be derived with noninvasive testing rather than
nvasive FFR remains unknown. Until then, no noninvasive
est—including MDCTA—should be used in isolation for
he determination of appropriateness of coronary revascu-
arization. Similarly, no invasive test—including FFR—
hould be used alone for the determination of appropriate-
ess of coronary revascularization. Instead, defining
ppropriateness of coronary revascularization is best left to
ocietal consensus, which at present requires careful consid-
ration of a complex interplay between patient symptoms,
oronary anatomy, and the results of functional tests.
eprint requests and correspondence: Dr. Daniel S. Berman,
irector, Cardiac Imaging Cedars-Sinai Medical Center, 8700
everly Boulevard, Room 1258, Los Angeles, California 90048.
-mail: bermand@cshs.org.
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